These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 24706802)
1. Differential ubiquitination and degradation of huntingtin fragments modulated by ubiquitin-protein ligase E3A. Bhat KP; Yan S; Wang CE; Li S; Li XJ Proc Natl Acad Sci U S A; 2014 Apr; 111(15):5706-11. PubMed ID: 24706802 [TBL] [Abstract][Full Text] [Related]
2. Herp Promotes Degradation of Mutant Huntingtin: Involvement of the Proteasome and Molecular Chaperones. Luo H; Cao L; Liang X; Du A; Peng T; Li H Mol Neurobiol; 2018 Oct; 55(10):7652-7668. PubMed ID: 29430620 [TBL] [Abstract][Full Text] [Related]
3. Degradation of mutant huntingtin via the ubiquitin/proteasome system is modulated by FE65. Chow WN; Luk HW; Chan HY; Lau KF Biochem J; 2012 May; 443(3):681-9. PubMed ID: 22352297 [TBL] [Abstract][Full Text] [Related]
4. Atypical ubiquitination by E3 ligase WWP1 inhibits the proteasome-mediated degradation of mutant huntingtin. Lin L; Jin Z; Tan H; Xu Q; Peng T; Li H Brain Res; 2016 Jul; 1643():103-12. PubMed ID: 27107943 [TBL] [Abstract][Full Text] [Related]
5. Inhibiting the ubiquitin-proteasome system leads to preferential accumulation of toxic N-terminal mutant huntingtin fragments. Li X; Wang CE; Huang S; Xu X; Li XJ; Li H; Li S Hum Mol Genet; 2010 Jun; 19(12):2445-55. PubMed ID: 20354076 [TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor receptor-associated factor 6 (TRAF6) associates with huntingtin protein and promotes its atypical ubiquitination to enhance aggregate formation. Zucchelli S; Marcuzzi F; Codrich M; Agostoni E; Vilotti S; Biagioli M; Pinto M; Carnemolla A; Santoro C; Gustincich S; Persichetti F J Biol Chem; 2011 Jul; 286(28):25108-17. PubMed ID: 21454471 [TBL] [Abstract][Full Text] [Related]
7. Clearance of mutant huntingtin. Li XJ; Li H; Li S Autophagy; 2010 Jul; 6(5):663-4. PubMed ID: 20519964 [TBL] [Abstract][Full Text] [Related]
8. The de-ubiquitinating enzyme ataxin-3 does not modulate disease progression in a knock-in mouse model of Huntington disease. Zeng L; Tallaksen-Greene SJ; Wang B; Albin RL; Paulson HL J Huntingtons Dis; 2013; 2(2):201-15. PubMed ID: 24683430 [TBL] [Abstract][Full Text] [Related]
9. Ubiquitin-activating enzyme activity contributes to differential accumulation of mutant huntingtin in brain and peripheral tissues. Wade BE; Wang CE; Yan S; Bhat K; Huang B; Li S; Li XJ J Neurosci; 2014 Jun; 34(25):8411-22. PubMed ID: 24948797 [TBL] [Abstract][Full Text] [Related]
10. The regulation of autophagosome dynamics by huntingtin and HAP1 is disrupted by expression of mutant huntingtin, leading to defective cargo degradation. Wong YC; Holzbaur EL J Neurosci; 2014 Jan; 34(4):1293-305. PubMed ID: 24453320 [TBL] [Abstract][Full Text] [Related]
11. Comparison of huntingtin proteolytic fragments in human lymphoblast cell lines and human brain. Toneff T; Mende-Mueller L; Wu Y; Hwang SR; Bundey R; Thompson LM; Chesselet MF; Hook V J Neurochem; 2002 Jul; 82(1):84-92. PubMed ID: 12091468 [TBL] [Abstract][Full Text] [Related]
12. Bifunctional anti-huntingtin proteasome-directed intrabodies mediate efficient degradation of mutant huntingtin exon 1 protein fragments. Butler DC; Messer A PLoS One; 2011; 6(12):e29199. PubMed ID: 22216210 [TBL] [Abstract][Full Text] [Related]
13. N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking. Orr AL; Li S; Wang CE; Li H; Wang J; Rong J; Xu X; Mastroberardino PG; Greenamyre JT; Li XJ J Neurosci; 2008 Mar; 28(11):2783-92. PubMed ID: 18337408 [TBL] [Abstract][Full Text] [Related]
14. Dysfunction of the ubiquitin ligase Ube3a may be associated with synaptic pathophysiology in a mouse model of Huntington disease. Maheshwari M; Samanta A; Godavarthi SK; Mukherjee R; Jana NR J Biol Chem; 2012 Aug; 287(35):29949-57. PubMed ID: 22787151 [TBL] [Abstract][Full Text] [Related]
15. IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosome. Thompson LM; Aiken CT; Kaltenbach LS; Agrawal N; Illes K; Khoshnan A; Martinez-Vincente M; Arrasate M; O'Rourke JG; Khashwji H; Lukacsovich T; Zhu YZ; Lau AL; Massey A; Hayden MR; Zeitlin SO; Finkbeiner S; Green KN; LaFerla FM; Bates G; Huang L; Patterson PH; Lo DC; Cuervo AM; Marsh JL; Steffan JS J Cell Biol; 2009 Dec; 187(7):1083-99. PubMed ID: 20026656 [TBL] [Abstract][Full Text] [Related]
16. A series of N-terminal epitope tagged Hdh knock-in alleles expressing normal and mutant huntingtin: their application to understanding the effect of increasing the length of normal Huntingtin's polyglutamine stretch on CAG140 mouse model pathogenesis. Zheng S; Ghitani N; Blackburn JS; Liu JP; Zeitlin SO Mol Brain; 2012 Aug; 5():28. PubMed ID: 22892315 [TBL] [Abstract][Full Text] [Related]
18. Huntingtin interacts with the cue domain of gp78 and inhibits gp78 binding to ubiquitin and p97/VCP. Yang H; Liu C; Zhong Y; Luo S; Monteiro MJ; Fang S PLoS One; 2010 Jan; 5(1):e8905. PubMed ID: 20126661 [TBL] [Abstract][Full Text] [Related]
19. PRMT5- mediated symmetric arginine dimethylation is attenuated by mutant huntingtin and is impaired in Huntington's disease (HD). Ratovitski T; Arbez N; Stewart JC; Chighladze E; Ross CA Cell Cycle; 2015; 14(11):1716-29. PubMed ID: 25927346 [TBL] [Abstract][Full Text] [Related]
20. Ubiquitin ligase Hrd1 enhances the degradation and suppresses the toxicity of polyglutamine-expanded huntingtin. Yang H; Zhong X; Ballar P; Luo S; Shen Y; Rubinsztein DC; Monteiro MJ; Fang S Exp Cell Res; 2007 Feb; 313(3):538-50. PubMed ID: 17141218 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]